Clinical Trials Activity Projected to Reach $68.9bn by 2026

Did you know clinical trial activity is projected to reach $68.9bn by 2026?

Ensure your European organisation is streamlining its’ operations by joining leading technology Pharma experts at the Disruptive Technology for Clinical Trials Europe Summit on 23 January 2024 in London, UK!

Join a series of collaborative discussions to ensure your technology roadmap is prepared to deal with this growth alongside Johnson and Johnson, Biogen, Bayer, AstraZeneca and more.

Reserve your spot >>>